Medical Condition News

RSS

A.P. Pharma announces additional data from APF530 Phase 3 study on CINV

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced additional data from the Company's Phase 3 study of APF530 for the prevention of chemotherapy-induced nausea and vomiting (CINV).

29 Jun 2012

FOXO1 gene may play an important role in pathological mechanisms of Parkinson's

A recent study led by researchers at Boston University School of Medicine (BUSM) revealed that the FOXO1 gene may play an important role in the pathological mechanisms of Parkinson's disease.

29 Jun 2012

Association between SCC and cutaneous HPV types

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida, the German Cancer Research Center in Heidelberg, and the International Agency for Research on Cancer in Lyon, France, conducted a case control study and found associations between having antibodies to certain types of cutaneous human papillomavirus (HPV) and a kind of skin cancer called squamous cell carcinoma (SCC).

29 Jun 2012

Rio+20 outcome document lacks commitment to NCDs

In this post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Sara Holtz, a senior technical officer at MSH, reports on the 53-page outcome document of the United Nations Conference on Sustainable Development (Rio+20), which took place in Rio de Janeiro, Brazil last week.

29 Jun 2012

More than 40,000 student athletes in Arizona receive Mayo Clinic baseline concussion testing

More than 40,000 student athletes in Arizona have taken advantage of computerized baseline concussion evaluations offered by Mayo Clinic in the program's first year. That amounts to nearly 40 percent of the state's roughly 100,000 high school athletes. Baseline concussion evaluations measure how the brain is working before injury, and are mandatory tests for professional and college athletes.

29 Jun 2012

Scientists successfully tag serotonin transporter to track movements of single molecules

In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.

29 Jun 2012

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced today the publication of results from two initial trials of LX4211 in patients with type 2 diabetes in the online edition of the journal Clinical Pharmacology & Therapeutics.

29 Jun 2012

Clergy's practice of putting others first can be detrimental to their own health

Clergy's practice of putting others first can be detrimental to their own health, say researchers at Duke University.

29 Jun 2012

UCSD surgeon first in the U.S. to implant new FDA-approved LINX for GERD

Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to implant the new FDA-approved LINX for GERD.

29 Jun 2012

Gluten-free diet may not be a good choice for everyone

One of the latest trends in the food market and among celebrities is going gluten-free. Snack giant Frito-Lay has announced it will introduce new gluten-free labels and products, and Miley Cyrus has credited her recent weight loss to a gluten-free diet.

29 Jun 2012

Blindsight in monkeys is available in everyday environments

The visual information from eyes is sent into the brain unconsciously even if you are not aware. One of examples of unconscious seeing is a phenomenon of "blindsight" [Subjects have no awareness, but their brains can see] in subjects with visual impairment, caused by the damage of a part of the brain called the visual cortex.

29 Jun 2012

ACR updates 39 appropriateness criteria topics and adds five new criteria

New and updated evidence-based guidelines to help health care providers choose the most appropriate medical imaging exam or radiation therapy for a patient's clinical condition are now available via the latest version of the American College of Radiology (ACR) Appropriateness Criteria.

29 Jun 2012

RUB biologists deliberately transform spinal cord stem cells into immature nerve cells

RUB biologists have deliberately transformed stem cells from the spinal cord of mice into immature nerve cells. This was achieved by changing the cellular environment, known as the extracellular matrix, using the substance sodium chlorate.

29 Jun 2012

Study reveals technique that allows scientists to watch lipid metabolism in live zebrafish

In mammals, most lipids are absorbed into the body via the small intestine. The complexity of the cells and fluids that inhabit this organ make it very difficult to study in a laboratory setting. New research from Carnegie's Steven Farber, James Walters and Jennifer Anderson reveals a technique that allows scientists to watch lipid metabolism in live zebrafish. This method enabled them to describe new aspects of lipid absorption that could have broad applications for human health.

29 Jun 2012

Low-level social capital can lead to mental ill-health among older people

Older people experiencing low-level social capital are more likely to suffer from mental ill-health and this risk group should have access to initiatives that empower social networking and a maintained rich social life. Researcher Anna Forsman at the Nordic School of Public Health NHV have examined how mental health can be promoted and mental health problems be prevented among older adults by using psychosocial initiatives.

29 Jun 2012

Researchers identify genes that influence degeneration of the hippocampus

In a genome-wide association (GWA) study, researchers from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) have identified several genes which influence degeneration of the hippocampus, the part of the brain most associated with Alzheimer disease (AD).

29 Jun 2012

Once-daily pill for HIV is a safe and effective alternative to traditional antiretroviral regimens

A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week’s Lancet also indicate that the new “Quad” pill is faster acting, doesn’t have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.

29 Jun 2012

New drug for Type 2 diabetes results in less hypoglycaemia, less weight gain and perhaps less cardiovascular risk for patients

A new drug could offer significant advantages over existing treatments for Type 2 diabetes patients who don’t respond to metformin, the most commonly prescribed initial drug treatment for the disease. The new drug, linagliptin, results in significantly less weight gain than the most common second-line treatments currently used, and may even carry a smaller risk of cardiovascular events such as heart attack and stroke, according to an Article published Online First in The Lancet.

29 Jun 2012

Novo Nordisk, BRI collaborate to speed-up translational research of autoimmune diseases

Benaroya Research Institute at Virginia Mason (BRI), a non-profit biomedical research institute in Seattle, Wash., and Novo Nordisk, a global health care company headquartered in Denmark, today announced a three-year collaborative agreement to potentially speed-up translational research of the diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease and lupus.

29 Jun 2012

Sinai Hospital begins to use Solitaire FR device for treatment of acute stroke

Sinai Hospital has begun use of a new device that provides timely live-saving treatment for acute stroke patients. The Solitaire FR revascularization device is designed to minimize damage caused by blockage of an artery to the brain by mechanically removing blood clots and restoring blood flow.

29 Jun 2012

Medical Condition News

A.P. Pharma announces additional data from APF530 Phase 3 study on CINV

FOXO1 gene may play an important role in pathological mechanisms of Parkinson's

Association between SCC and cutaneous HPV types

Rio+20 outcome document lacks commitment to NCDs

More than 40,000 student athletes in Arizona receive Mayo Clinic baseline concussion testing

Scientists successfully tag serotonin transporter to track movements of single molecules

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

Clergy's practice of putting others first can be detrimental to their own health

UCSD surgeon first in the U.S. to implant new FDA-approved LINX for GERD

Gluten-free diet may not be a good choice for everyone

Blindsight in monkeys is available in everyday environments

ACR updates 39 appropriateness criteria topics and adds five new criteria

RUB biologists deliberately transform spinal cord stem cells into immature nerve cells

Study reveals technique that allows scientists to watch lipid metabolism in live zebrafish

Low-level social capital can lead to mental ill-health among older people

Researchers identify genes that influence degeneration of the hippocampus

Once-daily pill for HIV is a safe and effective alternative to traditional antiretroviral regimens

New drug for Type 2 diabetes results in less hypoglycaemia, less weight gain and perhaps less cardiovascular risk for patients

Novo Nordisk, BRI collaborate to speed-up translational research of autoimmune diseases

Sinai Hospital begins to use Solitaire FR device for treatment of acute stroke

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News